Clinical Trials
3 trialsNCT02075840 2026-05-29
ALEX
Hoffmann-La Roche
Phase 3 Completed
NCT02314481 2026-05-04
DARWINII
University College, London
Phase 2 Completed
NCT06354387 2026-03-19
Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1
China Medical University Hospital
Phase 1 Completed